IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...
A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback